news
El Sudcaliforniano
2026-04-13
How Merck turned miracle drug into blockbuster, limiting access for cancer patients globally
The pharmaceutical giant has built a fortress of patents and lobbied extensively to protect its main revenue source, the drug Keytruda.
El gigante farmacéutico ha construido una fortaleza de patentes, ha operado con opacidad y ha cabildeado incansablemente para proteger a su principal fuente de ingresos: Keytruda